| |
| |
|
| Insider
Information: |
Edelman Joseph |
| Relationship: |
Former 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
42 |
|
| Direct
Shares |
630,171 |
|
|
Indirect Shares
|
332,164,708 |
|
|
| Direct
Value |
$1,466,262 |
|
|
|
Indirect Value
|
$2,852,575,947 |
|
|
| Total
Shares |
332,794,879 |
|
|
| Total
Value |
$2,854,042,209 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
79
|
21
|
|
Stock
price went up :
|
50
|
11
|
| Stock
price went down : |
29
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
1.7
|
1.1
|
| Percentage
Gain/Loss : |
 13.4%
|
197.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-06-23 |
0 |
2008-06-23 |
6,387,546 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
|
0 |
2011-11-02 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-11-01 |
133,133 |
2012-11-29 |
2,595,293 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
|
0 |
2017-06-19 |
4,533,728 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
10% Owner |
|
0 |
2014-07-25 |
2,610,356 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
|
0 |
2024-04-05 |
9,275,851 |
Premium* |
|
|
Aravive Inc |
ARAV |
10% Owner |
|
0 |
2017-09-22 |
2,099,563 |
Premium* |
|
|
Kadmon Holdings, Llc |
KDMN |
10% Owner |
|
0 |
2019-11-18 |
14,636,334 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2017-09-29 |
0 |
2018-08-10 |
4,070,357 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
10% Owner |
2017-12-19 |
0 |
2017-12-19 |
4,889,066 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2018-01-16 |
0 |
2018-10-12 |
2,724,686 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
10% Owner |
2018-01-25 |
0 |
2022-10-13 |
1,939,723 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
2018-01-30 |
0 |
2024-01-11 |
6,906,646 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
10% Owner |
2018-02-13 |
0 |
2019-01-08 |
2,253,376 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
10% Owner |
2018-02-16 |
0 |
2021-01-22 |
2,660,542 |
Premium* |
|
|
Quotient Ltd |
QTNTQ |
10% Owner |
2018-05-22 |
0 |
2022-10-31 |
7,945,211 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
10% Owner |
2018-06-04 |
0 |
2019-11-12 |
0 |
Premium* |
|
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2018-06-08 |
0 |
2023-05-05 |
11,281,103 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2018-07-26 |
0 |
2021-10-13 |
21,654,485 |
Premium* |
|
|
Verrica Pharmaceuticals Inc. |
VRCA |
10% Owner |
2018-06-19 |
0 |
2023-12-29 |
7,099,182 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
10% Owner |
2019-05-06 |
0 |
2020-09-14 |
13,532,467 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
10% Owner |
2019-05-21 |
0 |
2021-09-30 |
13,262,375 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2019-07-29 |
11,203,881 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director, 10% Owner |
2020-05-05 |
0 |
2023-05-31 |
12,757,563 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2020-06-09 |
0 |
2021-08-16 |
4,935,057 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2020-06-22 |
0 |
2020-06-22 |
8,476,496 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director, 10% Owner |
|
0 |
2023-12-29 |
5,402,964 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2020-10-20 |
0 |
2024-02-20 |
10,794,876 |
Premium* |
|
|
Scynexis Inc |
SCYX |
10% Owner |
2021-01-20 |
0 |
2021-01-22 |
1,800,000 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
|
0 |
2021-02-09 |
17,960,839 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director |
|
0 |
2024-02-01 |
6,485,420 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,314,032 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2021-04-27 |
0 |
2021-10-12 |
2,487,019 |
Premium* |
|
|
Nautilus Biotechnology, Inc |
NAUT |
10% Owner |
2021-05-24 |
497,038 |
2021-12-08 |
9,111,151 |
Premium* |
|
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
3,554,587 |
Premium* |
|
|
Lianbio |
LIAN |
Director, 10% Owner |
|
0 |
2024-02-15 |
57,575,533 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
|
0 |
2024-04-11 |
5,360,858 |
Premium* |
|
|
Chembio Diagnostics Inc |
CEMI |
Former 10% Owner |
2023-04-04 |
0 |
2023-04-27 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2023-06-06 |
2,207,753 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
Former 10% Owner |
2023-11-14 |
0 |
2023-11-14 |
333,333 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2021-09-27 |
4 |
S |
$1.23 |
$307,500 |
I/I |
(250,000) |
13,522,978 |
0 |
% |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2021-09-24 |
4 |
S |
$1.26 |
$315,000 |
I/I |
(250,000) |
13,772,978 |
0 |
% |
|
| LIAN |
Lianbio |
Director |
– • • |
2022-05-25 |
4 |
B |
$2.63 |
$315,600 |
I/I |
120,000 |
2,661,251 |
2.25 |
- |
|
| AGRX |
Agile Therapeutics Inc |
10% Owner |
– – • |
2019-10-29 |
4 |
S |
$0.44 |
$334,528 |
I/I |
(760,291) |
6,151,110 |
0 |
- |
|
| VRCA |
Verrica Pharmaceuticals I... |
10% Owner |
– – • |
2023-12-26 |
4 |
B |
$6.49 |
$354,691 |
I/I |
54,652 |
6,777,566 |
1.5 |
% |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
B |
$17.90 |
$372,069 |
I/I |
20,786 |
9,820,623 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2018-10-03 |
4 |
B |
$12.69 |
$380,700 |
I/I |
30,000 |
20,724,424 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2023-06-02 |
4 |
B |
$5.93 |
$383,256 |
I/I |
64,630 |
2,129,085 |
1.5 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • • |
2023-12-29 |
4 |
B |
$2.38 |
$390,211 |
I/I |
163,954 |
5,402,964 |
2.25 |
- |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-09-16 |
4 |
B |
$13.58 |
$407,400 |
I/I |
30,000 |
10,735,245 |
1.5 |
- |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-06-21 |
4 |
B |
$17.85 |
$411,853 |
I/I |
23,073 |
9,799,837 |
1.5 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2012-11-21 |
4 |
B |
$20.75 |
$415,000 |
I/I |
20,000 |
2,495,293 |
1.5 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2012-11-20 |
4 |
B |
$21.01 |
$420,200 |
I/I |
20,000 |
2,475,293 |
1.5 |
- |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2021-08-19 |
4 |
S |
$1.24 |
$434,436 |
I/I |
(350,352) |
14,802,978 |
0 |
% |
|
| VYNE |
VYNE Therapeutics Inc |
10% Owner |
– – • |
2021-08-16 |
4 |
S |
$1.74 |
$435,000 |
I/I |
(250,000) |
4,935,057 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2020-10-21 |
4 |
B |
$10.09 |
$435,838 |
I/I |
43,195 |
157,295 |
2.1 |
% |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-08-15 |
4 |
B |
$15.00 |
$450,000 |
I/I |
30,000 |
10,615,245 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2008-06-23 |
4 |
B |
$5.00 |
$457,500 |
I/I |
91,500 |
6,387,546 |
1.5 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
10% Owner |
– – • |
2021-08-13 |
4 |
S |
$1.84 |
$460,000 |
I/I |
(250,000) |
5,185,057 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2023-06-05 |
4 |
B |
$5.98 |
$469,239 |
I/I |
78,468 |
2,207,553 |
1.5 |
- |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-08-08 |
4 |
B |
$15.76 |
$472,800 |
I/I |
30,000 |
10,585,245 |
1.5 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
10% Owner |
– – • |
2019-07-09 |
4 |
B |
$16.61 |
$495,543 |
I/I |
29,834 |
3,653,435 |
1.5 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2023-10-18 |
4 |
S |
$1.74 |
$533,308 |
I/I |
(306,499) |
8,593,586 |
0 |
% |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-10-17 |
4 |
B |
$10.93 |
$546,500 |
I/I |
50,000 |
10,852,467 |
1.5 |
- |
|
| VRCA |
Verrica Pharmaceuticals I... |
10% Owner |
– – • |
2023-12-27 |
4 |
B |
$7.20 |
$574,027 |
I/I |
79,726 |
6,857,292 |
1.5 |
% |
|
304 Records found
|
|
Page 5 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
